A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment...08/22/2013 - 06/30/2022 (PI)
Abbott Laboratories
A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous c05/01/2010 - 04/30/2015 (PI)
Harvard Clinical Research Institute
Gravitas: Gauging Responsivness with a Verify Now Assay-Impact on Thrombsis and Safety10/01/2008 - 09/30/2012 (PI)
Accumetrics
Xience V Everolimus Eluting Coronary Stent System Post-Approval Study (EECSS)09/01/2008 - 05/31/2012 (PI)
Abbott Laboratories
Tilarginine Acetate Injection in a Randomized International Study in Unstable AMI Patients / Cardiogenic Shock07/01/2005 - 06/30/2007 (PI)
Arginox
D.E.S. Cover Registry04/13/2005 - 04/12/2007 (PI)
Cordis Corporation
The GUARD Trial Saphenous Vein Graft Intervention Using AngioGuard for Reduction of Distal Embolization11/29/2000 - 12/31/2005 (PI)
Cordis Corporation
Clopidogrel for Reduction of Events During Observation (CREDO)08/25/2000 - 08/31/2001 (PI)
Sanofi Pharmaceuticals Inc (from Cleveland Clinic Foundation) Bristol-Myers Squibb
XaNADU PCI Pilot Trial01/22/2001 - 05/31/2001 (PI)
Duke University
Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study06/01/2015 - 05/31/2018 (PI)
Duke University Astrazeneca Pharmace
SILVER-AMI : Risk Stratification in Older Persons with Acute Myocardial Infarction06/01/2013 - 05/31/2018 (PI)
Yale University NIH-NHLBI5R01HL115295-04
MASS COMM Trial08/30/2006 - 06/30/2014 (PI)
Harvard Clinical Research Institute DPH
VIRGO study04/01/2009 - 05/01/2014 (PI)
Yale University NIH-NHLBIR01 HL081153
Occluded Artery Trial (OAT)02/01/2001 - 12/31/2010 (PI)
New York University DHHSU01 HL62509
Bari 2 Diabetes (BARI 2D) Data Coordinating Center01/01/2001 - 09/30/2010 (PI)
University of Pittsburgh DHHS5 U01 HL61744-03
FREEDOM (Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management06/22/2006 - 12/31/2007 (PI)
Mount Sinai Medical Center NIH-NHLBI1 R01 HL 071988-01A1
SHOCK II Phase 2 Trial11/01/2003 - 10/30/2005 (PI)
Arginox Pharmaceuticals NIH-NHLBI
Mechanisms Of Pro Thrombosis I07/01/2001 - 06/30/2005 (PI)
University of Vermont NIH-NHLBI1R01HL6914601